Comparing two approaches to physical activity in breast cancer patients

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to evaluate the effects of different physical activity approaches on breast cancer patients who have completed their treatment. It focuses on assessing the patients' exercise capacity and overall quality of life through the 6-minute walk test, which measures cardiorespiratory fitness. The study recognizes the complications that arise from breast cancer treatments and seeks to personalize rehabilitation programs to address individual needs. By understanding the impact of physical activity on recovery, the study hopes to enhance the functional capacity and quality of life for these patients.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Being between 18-65 years of age,
2. Volunteering to participate in the research,
3. At least 15 months after breast cancer surgery,
4. Six months after active breast cancer treatment (i.e. surgery/chemotherapy),
5. No problems in reading and/or understanding the scales and being able to cooperate with the tests,

Exclusion Criteria:

1. Presence of active infection,
2. Musculoskeletal and neurological diseases that may affect exercise performance, symptomatic heart disease,
3. Have a neurological disease or other clinical diagnosis that may affect cognitive status.
4. Musculoskeletal and neurologic disease, symptomatic heart disease, previous lung surgery and malignant disease that may affect exercise performance.
5. Presence of unstable hypertension or diabetes mellitus

Where it's running

• Ebru Çalık Kutukcu
  Ankara, Hacettepe Unıversity, Turkey Recruiting

Study contacts

• Principal investigator: Ebru Calik-Kutukcu, PhD — Hacettepe University
• Study coordinator: Ebru Calik Kutukcu, PhD
• Email: ebru.calik@hacettepe.edu.tr
• Phone: +903123051576

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Gyrotonic exercise for elders with breast cancer and Behcet disease

  We’re testing whether a gyrotonic exercise program helps older people who have both Behcet disease and breast cancer.

  Recruiting Cairo University · Giza, Dokki · NCT07929116

• PECS II vs SPSIP nerve blocks for pain after mastectomy

  This study tests whether two ultrasound-guided nerve blocks (PECS II and SPSIP) differ in how much opioid patients need after mastectomy.

  Recruiting Bursa City Hospital · Nilufer, Bursa · NCT07929090

• CG-7321: a first-in-human test in advanced solid tumors

  We’re testing CG-7321 alone and with fulvestrant to see if it’s safe and tolerable in adults with advanced solid tumors.

  Recruiting at 4 sites Phase 1 Chengdu Cynogen Bio-pharmaceutical Tech. Co., Ltd. · Fuzhou, Fujian and 3 other locations · NCT07923214

• Compare a new endoscopy-assisted breast-conserving surgery with the usual approach

  This study tests whether a new endoscopy-assisted breast-conserving technique can provide similar or better cosmetic outcomes and safety compared with conventional breast-conserving surgery in women with early breast cancer who want to preserve their breast.

  Recruiting Sir Run Run Shaw Hospital · Hangzhou, Zhejiang and 21 other locations · NCT07920094

• Different skin care approaches to prevent skin reactions after mastectomy radiation

  This study tests three standard skin care methods to see which best prevents radiation dermatitis in people who had a mastectomy and are receiving post-mastectomy radiation therapy.

  Recruiting at 7 sites Phase 2 Memorial Sloan Kettering Cancer Center · Basking Ridge, New Jersey and 6 other locations · NCT07918989

• 3D Heart Strain to Detect Early Cardiotoxicity in Cancer Therapy

  This study tests whether 3D echocardiography can detect early heart damage from cancer treatments like anthracyclines or HER2-targeted therapy better than standard 2D methods.

  Recruiting Region Skane · Lund, Skåne County · NCT07916337

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.